Research graph
References from Engineering smart polymeric lipid nanoparticles for breast cancer: The convergence of AI and medical personalization to enhance efficacy and safety. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Targeted cancer therapy: the next generation of cancer treatment
10.2174/1570163812666150602144310 · 2015 · External reference
Nanotechnology development in surgical applications: recent trends and developments
10.1186/s40001-023-01429-4 · 2023 · External reference
Omics approaches for the assessment of biological responses to nanoparticles
10.1016/j.addr.2023.114992 · 2023 · External reference
Advancing nanoparticle production: scaling up techniques, challenges, and future perspectives in pharmaceutical applications
2025 · External reference
Liquid biopsy: an evolving paradigm for non-invasive disease diagnosis and monitoring in medicine
2023 · External reference
Applications of nanobiotechnology in medicine
10.3390/life16020302 · 2026 · External reference
An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism
10.1080/17425247.2024.2318459 · 2024 · External reference
Cartilage‐targeting ultrasmall lipid‐polymer hybrid nanoparticles for the prevention of cartilage degradation
10.1002/btm2.10187 · 2021 · External reference
Predictive design and analysis of drug transport by multiscale computational models under uncertainty
10.1007/s11095-022-03298-8 · 2023 · External reference
Ribociclib hybrid lipid–polymer nanoparticle preparation and characterization for cancer treatment
10.3390/polym15132844 · 2023 · External reference
Green nanoparticles in drug delivery: translational challenges and AI solutions
10.1016/j.nxmate.2026.103081 · 2026 · External reference
ADAM 8 as a novel target for doxorubicin delivery to TNBC cells using magnetic thermosensitive liposomes
10.1016/j.ejpb.2020.12.012 · 2021 · External reference
The chemotherapeutic efficacy of hyaluronic acid coated polymeric nanoparticles against breast cancer metastasis in female NCr-Nu/Nu nude mice
10.3390/polym15020284 · 2023 · External reference
Enhancing drug efficacy through nanoparticle-based delivery systems: a study on targeted cancer therapy
10.1097/js9.0000000000002702 · 2025 · External reference
FAIR assessment of nanosafety data reusability with community standards
10.1038/s41597-024-03324-x · 2024 · External reference
Leveraging artificial intelligence for synergies in drug discovery: from computers to clinics
10.2174/0113816128308066240529121148 · 2024 · External reference
Nanohybrid nanozyme based colourimetric immunosensor for porcine gelatin
10.1016/j.foodchem.2023.137947 · 2024 · External reference
Unresolved reference
External reference
Mathematical modeling of micro-/nanoparticles transport in blood vessels: a review
10.1007/s11814-024-00071-y · 2024 · External reference
Unresolved reference
External reference
Prospective de novo drug design with deep interactome learning
10.1038/s41467-024-47613-w · 2024 · External reference
Lipoparticles: lipid-coated PLA nanoparticles enhanced in vitro mRNA transfection compared to liposomes
10.3390/pharmaceutics13030377 · 2021 · External reference
Intelligent nanoparticle design: Unlocking the potential of AI for transformative drug delivery
2025 · External reference
Unresolved reference
2025 · External reference
Toward a systematic exploration of nano-bio interactions
10.1016/j.taap.2017.03.011 · 2017 · External reference
Structural studies of KCTD1 and its disease-causing mutant P20S provide insights into the protein function and misfunction
10.1016/j.ijbiomac.2024.134390 · 2024 · External reference
Predicting the toxicity of nanoparticles using artificial intelligence tools: a systematic review
10.1080/17435390.2023.2186279 · 2023 · External reference
Highlights on cell-penetrating peptides and polymer-lipid hybrid nanoparticle: overview and therapeutic applications for targeted anticancer therapy
10.1208/s12249-023-02576-x · 2023 · External reference
Doxil®–the first FDA-approved nano-drug: lessons learned
10.1016/j.jconrel.2012.03.020 · 2012 · External reference
A stepwise framework for the systematic development of lipid nanoparticles
10.3390/biom12020223 · 2022 · External reference
3D printed tablets loaded with polymeric nanocapsules: an innovative approach to produce customized drug delivery systems
10.1016/j.ijpharm.2017.05.074 · 2017 · External reference
Precision oncology reimagined: smart nano carriers and ai-guided multi-omics strategies
2025 · External reference
Physics-inspired transfer learning for ML-prediction of CNT band gaps from limited data
10.1038/s41524-024-01247-0 · 2024 · External reference
PEGylated erlotinib HCl injectable nanoformulation for improved bioavailability
10.1208/s12249-023-02560-5 · 2023 · External reference
10.70593/978-93-7185-537-2_5
10.70593/978-93-7185-537-2_5 · External reference
Artificial intelligence-driven strategies for targeted delivery and enhanced stability of RNA-based lipid nanoparticle cancer vaccines
10.3390/pharmaceutics17080992 · 2025 · External reference
Design and production of hybrid nanoparticles with polymeric-lipid shell–core structures: conventional and next-generation approaches
10.1039/c8ra07069e · 2018 · External reference
Polymer–lipid pharmaceutical nanocarriers: innovations by new formulations and production technologies
10.3390/pharmaceutics13020198 · 2021 · External reference
Interpretation of network-based integration from multi-omics longitudinal data
10.1093/nar/gkab1200 · 2022 · External reference
Electrochemotherapy of deep-seated tumors: state of art and perspectives as possible “EPR effect enhancer” to improve cancer nanomedicine efficacy
10.3390/cancers13174437 · 2021 · External reference
Application of nanoparticles in breast cancer treatment: a systematic review
10.1007/s00210-024-03082-y · 2024 · External reference
Recent progress in lipid nanoparticles for cancer theranostics: opportunity and challenges
10.3390/pharmaceutics13060840 · 2021 · External reference
The roles of plant-derived extracellular vesicles in cancer: focusing on drug delivery, anti-cancer immunity and renin-angiotensin system
10.1177/14703203261432784 · 2026 · External reference
Artificial intelligence in materials characterization: methods, applications, and future perspectives
2025 · External reference
Deciphering key nano-bio interface descriptors to predict nanoparticle-induced lung fibrosis
10.1186/s12989-024-00616-3 · 2025 · External reference
Unresolved reference
External reference
Artificial intelligence for breast cancer screening in mammography (AI-STREAM): preliminary analysis of a prospective multicenter cohort study
10.1038/s41467-025-57469-3 · 2025 · External reference
Nanocarriers for the delivery of medical, veterinary, and agricultural active ingredients
10.1021/acsnano.0c00173 · 2020 · External reference
Lipid-based nanoparticles as a pivotal delivery approach in triple negative breast cancer (TNBC) therapy
10.3390/ijms231710068 · 2022 · External reference
Lipid-polymer hybrid nanoparticles loaded with pazopanib for the enhanced anticancer efficacy against triple-negative breast cancer
10.1007/s12668-025-02324-4 · 2026 · External reference
From GROMACS to LAMMPS: GRO2LAM: a converter for molecular dynamics software
10.1007/s00894-019-4011-x · 2019 · External reference
Self-assemble peptide biomaterials and their biomedical applications
2019 · External reference
Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer
10.1016/j.canlet.2014.12.052 · 2015 · External reference
Utilising high-dimensional data in randomised clinical trials: a review of methods and practice
2024 · External reference
Machine learning and artificial intelligence in nanomedicine
10.1002/wnan.70027 · 2025 · External reference
Nanoparticles as surrogates of antibiotics: a comprehensive review
10.55248/gengpi.5.0324.0885 · 2024 · External reference
Next-generation smart drug delivery: biosensor-integrated closed-loop therapeutics (CLT) for regenerative medicine
10.1016/j.nxbio.2026.100027 · 2026 · External reference
Employing nano-enabled artificial intelligence (AI)-based smart technologies for prediction, screening, and detection of cancer
10.1039/d3nr05648a · 2024 · External reference
Polymer/lipid core-shell nanoconstructs for cancer theragnostic
2025 · External reference
An unbiased seed-based RNAi selection screen identifies small RNAs that inhibit androgen signaling and prostate cancer cell growth
10.1016/j.omtn.2023.06.021 · 2023 · External reference
Progress on drug nanoparticle manufacturing: exploring the adaptability of batch bottom-up approaches to continuous manufacturing
10.1016/j.jddst.2025.107120 · 2025 · External reference
Nanocarriers for anticancer drug targeting: recent trends and challenges
2021 · External reference
In-silico strategies in nano-drug design: bridging nanomaterials and pharmacological applications
10.1016/j.ntm.2025.100091 · 2025 · External reference
Breast cancer detection using random forest supported by feature selection
2024 · External reference
AI in infectious diseases: The role of datasets
2024 · External reference
Sub-15 nm nanoparticles for drug delivery: emerging frontiers and therapeutic potential
10.3390/ijms262210842 · 2025 · External reference
Immunotherapy in breast cancer: an overview of current strategies and perspectives
10.1038/s41523-023-00508-3 · 2023 · External reference
Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape
10.1002/smll.202502315 · 2025 · External reference
Cell membrane‐coated nanoparticles: a new frontier in immunomodulation
10.1002/anbr.202400012 · 2024 · External reference
Posaconazole loaded lipid polymer hybrid nanoparticles: design and development for vaginal drug delivery
10.1007/s12247-024-09898-8 · 2025 · External reference
Lipid-polymer hybrid nanoparticles loaded hydrogel formulation for enhanced topical delivery of itraconazole: in vitro and in vivo studies
10.1007/s12668-025-02330-6 · 2026 · External reference
Emerging paradigms in personalized oncology: role of nano therapeutics and AI across liver, breast, renal, and brain cancers
2025 · External reference
Next-gen cancer therapy: the convergence of artificial intelligence, nanotechnology, and digital twin
2025 · External reference
Systems-level exploration of Withania somnifera-derived phytochemicals against breast cancer: a network pharmacology and molecular modeling approach
10.1016/j.compbiomed.2025.111367 · 2026 · External reference
Advances in the use of nanoparticles for specific cell-target delivery of anti-cancer agents
10.1016/j.lfs.2025.123604 · 2025 · External reference
Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes
10.1007/s13346-022-01262-y · 2022 · External reference
Long noncoding RNA MIR210HG promotes the warburg effect and tumor growth by enhancing HIF-1α translation in triple-negative breast cancer
2020 · External reference
Dose-dense chemotherapy versus conventional chemotherapy for early breast cancer: a systematic review with meta-analysis
10.1016/j.breast.2012.02.011 · 2012 · External reference
Nationwide real-world implementation of AI for cancer detection in population-based mammography screening
10.1038/s41591-024-03408-6 · 2025 · External reference
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
10.1016/j.nano.2012.05.015 · 2013 · External reference
Improving nanoparticle size estimation from scanning transmission electron micrographs with a multislice surrogate model
10.1021/acs.nanolett.4c06025 · 2025 · External reference
Electrosprayed core–shell polymer–lipid nanoparticles for active component delivery
10.1088/0957-4484/24/46/465604 · 2013 · External reference
Novel pH-triggered biocompatible polymeric micelles based on heparin–α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer
10.1080/10837450.2019.1711395 · 2020 · External reference
Artificial intelligence–guided nanoparticle design for advanced targeted drug delivery
10.34172/bi.33066 · 2025 · External reference
Overcoming chemotherapy resistance in metastatic cancer: a comprehensive review
10.3390/biomedicines12010183 · 2024 · External reference
A green strategy for resveratrol nanodelivery: a multidisciplinary approach for the physicochemical characterization of Thymus-based liposomes with anti-biofilm activity against Listeria monocytogenes
10.1016/j.jddst.2026.108027 · 2026 · External reference
Harnessing the power of stimuli‐responsive nanoparticles as an effective therapeutic drug delivery system
10.1002/adma.202312939 · 2024 · External reference
Advancements in polymeric nanocarriers to mediate targeted therapy against triple-negative breast cancer
10.3390/pharmaceutics14112432 · 2022 · External reference
Folic acid conjugated poly (amidoamine) dendrimer as a smart nanocarriers for tracing, imaging, and treating cancers over-expressing folate receptors
10.1016/j.eurpolymj.2022.111156 · 2022 · External reference
Scale-up of nanoparticle manufacturing process
2023 · External reference
Examination of low ERBB2 protein expression in breast cancer tissue
10.1001/jamaoncol.2021.7239 · 2022 · External reference
Recent advances in tumor targeting via EPR effect for cancer treatment
2021 · External reference
Novel amphiphilic copolymers as stabilizers for glyceryl monooleate-based lipid–polymer hybrid nanoparticles
10.1039/d5sm00831j · 2026 · External reference
Regulatory pathways supporting expedited drug development and approval in ICH member countries
10.1007/s43441-022-00480-3 · 2023 · External reference
Unresolved reference
2025 · External reference
Emerging lipid–polymer hybrid nanoparticles for genome editing
10.1039/d4py00298a · 2024 · External reference
Unresolved reference
2026 · External reference
Microfluidic-assisted silk nanoparticles co-loaded with epirubicin and copper sulphide: a synergistic photothermal–photodynamic chemotherapy against breast cancer
10.3390/nano15030221 · 2025 · External reference
Precision medicine: from science to value
10.1377/hlthaff.2017.1624 · 2018 · External reference
Engineered PLGA Core–Lipid shell hybrid nanocarriers improve the efficacy and safety of Irinotecan to combat colon cancer
10.1021/acsbiomaterials.4c01260 · 2024 · External reference
Integration of data‐driven techniques in nanomedicines to address diagnosis and drug delivery strategy for therapy
10.1002/bdd.70016 · 2025 · External reference
Polymer-lipid hybrid materials
10.1021/acs.chemrev.1c00755 · 2021 · External reference
A smart multiantenna gene theranostic system based on the programmed assembly of hypoxia-related siRNAs
10.1038/s41467-021-24191-9 · 2021 · External reference
Machine learning in drug delivery
10.1016/j.jconrel.2024.06.045 · 2024 · External reference
Folate receptor-mediated delivery of mitoxantrone-loaded solid lipid nanoparticles to breast cancer cells
10.1016/j.biopha.2022.113525 · 2022 · External reference
Polymer–drug and polymer–protein conjugated nanocarriers: design, drug delivery, imaging, therapy, and clinical applications
10.1002/wnan.1988 · 2024 · External reference
Hypoxia-driven ncRNAs in breast cancer
2023 · External reference
Intelligence prediction of microfluidically prepared nanoparticles
10.1038/s41598-025-21471-y · 2025 · External reference
Exciting potential of nanoparticlized lipidic system for effective treatment of breast cancer and clinical updates: a translational prospective
10.2174/1381612826666200131101156 · 2020 · External reference
Lipid-polymer hybrid nanoparticles as a smart drug delivery system for peptide/protein delivery
10.3390/pharmaceutics17060797 · 2025 · External reference
Quercetin-loaded solid lipid nanoparticles exhibit antitumor activity and suppress the proliferation of triple-negative MDA-MB 231 breast cancer cells: implications for invasive breast cancer treatment
10.1007/s11033-023-08848-w · 2023 · External reference
From omics to multi-omics: a review of advantages and tradeoffs
10.3390/genes15121551 · 2024 · External reference
Nanomaterial adjuvants for veterinary vaccines: mechanisms and applications
10.34133/research.0761 · 2025 · External reference
Artificial intelligence in nanotechnology for treatment of diseases
10.1080/1061186x.2024.2393417 · 2024 · External reference
Self-driving laboratories: a paradigm shift in nanomedicine development
10.1016/j.matt.2023.02.007 · 2023 · External reference
Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression
2022 · External reference
Artificial intelligence-driven pharmaceutical industry: a paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance
10.1016/j.ejps.2024.106938 · 2024 · External reference
GSH-sensitive Pt (IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer
10.7150/thno.29820 · 2019 · External reference
HIF-responsive lncRNAs define an immunosuppressive phenotype and predict anti-angiogenic response in clear cell renal cell carcinoma
10.1177/14703203251401461 · 2026 · External reference
High pressure homogenization–an update on its usage and understanding
10.1016/j.cherd.2023.12.026 · 2024 · External reference
Unresolved reference
2024 · External reference
Multi-omics integration for the design of novel therapies and the identification of novel biomarkers
2023 · External reference
Toward predictable nanomedicine: current forecasting frameworks for nanoparticle–biology interactions
10.1002/aidi.202500205 · 2026 · External reference
Innovations in nanoemulsion technology: enhancing drug delivery for oral, parenteral, and ophthalmic applications
10.3390/pharmaceutics16101333 · 2024 · External reference
Utilizing machine learning and molecular dynamics for enhanced drug delivery in nanoparticle systems
10.1038/s41598-024-73268-0 · 2024 · External reference
Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer
10.2217/nnm-2017-0011 · 2017 · External reference
Lipid–polymer hybrid nanosystems: a rational fusion for advanced therapeutic delivery
10.3390/jfb14090437 · 2023 · External reference
Recent advances in polymer-based nanoparticles: current strategies and translational challenges in cancer therapy
2025 · External reference
Revolutionizing medical practice: the impact of artificial intelligence (AI) on healthcare
10.33140/oajast.02.01.07 · 2024 · External reference
Smart nanomedicines for neurodegenerative diseases: empowering new therapies with molecular imaging and artificial intelligence
10.1007/s40291-025-00813-6 · 2026 · External reference
Chemistry and art of developing lipid nanoparticles for biologics delivery: focus on development and scale-up
10.3390/pharmaceutics16010131 · 2024 · External reference
Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours
10.1038/s41416-023-02185-2 · 2023 · External reference
Polymeric lipid hybrid nanoparticles: properties and therapeutic applications
2018 · External reference
10.1007/978-3-032-04008-4_20
10.1007/978-3-032-04008-4_20 · External reference
Polymeric micelles for breast cancer therapy: recent updates, clinical translation and regulatory considerations
10.3390/pharmaceutics14091860 · 2022 · External reference
MicroRNAs in oncology: a translational perspective in the era of AI
2026 · External reference
Machine learning reinforced genetic algorithm for massive targeted discovery of selectively cytotoxic inorganic nanoparticles
10.1002/smll.202305375 · 2024 · External reference
Artificial intelligence nanoparticle-based drug delivery systems and targeted delivery of therapeutics for the treatment of cardiovascular diseases: a systematic review
2025 · External reference
Integrative omics for health and disease
10.1038/nrg.2018.4 · 2018 · External reference
Selenium nanoparticles in prostate cancer: a dual-edged sword of therapeutic potential and toxicity
2025 · External reference
Inhaled ivermectin-loaded lipid polymer hybrid nanoparticles: Development and characterization
10.3390/pharmaceutics16081061 · 2024 · External reference
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation
10.1080/17435889.2024.2387530 · 2024 · External reference
AI-powered prediction of nanoparticle pharmacokinetics: a multi-view learning approach
2025 · External reference
Unresolved reference
2026 · External reference
Breast cancer multicellular spheroid models—a tool for studying cancer biology; a possible platform for drug screening and personalized medicine
10.3390/ijms27031314 · 2026 · External reference
The role of hypoxia-inducible factor isoforms in breast cancer and perspectives on their inhibition in therapy
2022 · External reference
Ionic liquids, nanofluids and nanotechnology: innovations
2026 · External reference
Role of artificial intelligence in optimizing nanocarriers for nucleic acid delivery, nanotechnology for nucleic acid delivery
2026 · External reference
A narrative review on artificial intelligence in advanced drug delivery systems: nanomedicine gems and smart robotics
2026 · External reference
Plant-derived nanoparticles in cancer therapy: a comprehensive review of recent advances and future prospects
10.21926/obm.genet.2503308 · 2025 · External reference
One-on-one comparison between conventional CAD and AI-CAD applied to screening mammography
2023 · External reference
Quality by design for the nanoformulation of cosmeceuticals
10.3390/pharmaceutics18010062 · 2026 · External reference
Oxygen-based nanocarriers to modulate tumor hypoxia for ameliorated anti-tumor therapy: fabrications, properties, and future directions
2021 · External reference
Antibody-specific detection of CAIX in breast and prostate cancers
10.1016/j.bbrc.2009.06.064 · 2009 · External reference
Deep learning for urban land use category classification: a review and experimental assessment
10.1016/j.rse.2024.114290 · 2024 · External reference
Polymeric lipid hybrid nanoparticles as a delivery system enhance the antitumor effect of emodin in vitro and in vivo
10.1016/j.xphs.2021.04.006 · 2021 · External reference
Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy
10.1016/j.jconrel.2022.03.021 · 2022 · External reference
Inorganic nanoparticles applied as functional therapeutics
2021 · External reference
Efficient non-viral siRNA carriers for triple-negative breast cancer: advances in 2020–2025
10.1016/j.matdes.2026.115506 · 2026 · External reference
Engineered nanomaterials for overcoming multifaceted gastrointestinal barriers: toward precision oral delivery of therapeutics
10.1016/j.phrs.2025.107844 · 2025 · External reference
Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
10.1007/s13346-025-01940-7 · 2025 · External reference
Engineering of redox-triggered polymeric lipid hybrid nanocarriers for selective drug delivery to cancer cells
10.1039/d4tb01236d · 2025 · External reference
Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives
10.1186/s40644-023-00557-8 · 2023 · External reference
Lipid nanoparticle development in practice: challenges and collective insights
2026 · External reference
MRI surveillance and breast cancer mortality in women with BRCA1 and BRCA2 sequence variations
10.1001/jamaoncol.2023.6944 · 2024 · External reference
Resistance and overcoming resistance in breast cancer
2020 · External reference
A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs
10.1186/s40824-023-00465-9 · 2023 · External reference
Development of polymer–lipid hybrid nanoparticles for large-sized plasmid DNA transfection
10.1021/acsami.3c14714 · 2023 · External reference
10.22201/ceiich.24485691e.2023.31.69797
10.22201/ceiich.24485691e.2023.31.69797 · External reference
Developments in genetics: better management of ovarian cancer patients
10.3390/ijms242115987 · 2023 · External reference
A narrative review on lipid-polymer hybrid nanoparticles for geriatric oncology: advancing drug delivery in the aging population
10.4103/agingadv.agingadv-d-24-00026 · 2025 · External reference
A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer
10.1007/s12551-019-00503-8 · 2019 · External reference
Omics-based functional fingerprinting of nanoparticles in cancer: toward predictive nanomedicine
10.3390/ijms27041960 · 2026 · External reference
Investigating hybrid PLGA-lipid nanoparticles as an innovative delivery tool for palmitoylethanolamide to muscle cells
10.3390/pharmaceutics17111412 · 2025 · External reference
Advancements in solid lipid nanoparticles and nanostructured lipid carriers for breast cancer therapy
10.2174/0113816128319233240725103706 · 2024 · External reference
Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes
10.1080/17425247.2024.2440618 · 2025 · External reference
Revolutionizing intelligent food packaging: nanomaterials, AI-ML, and their seamless integration
2026 · External reference
Targeted polymer lipid hybrid nanoparticles for in-vitro siRNA therapy in triple-negative breast cancer
10.1016/j.jddst.2024.105911 · 2024 · External reference
Exploring the cytotoxic and antioxidant properties of lanthanide-doped ZnO nanoparticles: a study with machine learning interpretation
10.1186/s12951-024-02957-9 · 2024 · External reference
A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research
10.1038/s41565-024-01673-7 · 2024 · External reference
Advancing prussian blue nanoparticle-mediated photothermal therapy through machine learning and multiomics integration
2026 · External reference
Nanomaterials in drug delivery and pharmaceutical applications: a review
10.1142/s1793984426300013 · 2026 · External reference
Liposomes as versatile drug delivery vehicles: emerging trends, technological innovations and future perspectives
2026 · External reference
Fast and accurate nanoparticle characterization using deep-learning-enhanced off-axis holography
10.1021/acsnano.0c06902 · 2021 · External reference
A survey of explainable artificial intelligence in healthcare: concepts, applications, and challenges
2024 · External reference
Unresolved reference
2024 · External reference
Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
10.34172/bi.2021.27 · 2020 · External reference
Overview of solid lipid nanoparticles in breast cancer therapy
10.3390/pharmaceutics15082065 · 2023 · External reference
Current advances in niosomes applications for drug delivery and cancer treatment
2023 · External reference
Next-generation nanocarriers for colorectal cancer: passive, active, and stimuli-responsive strategies for precision therapy
10.1039/d5bm01176k · 2025 · External reference
10.26434/chemrxiv-2023-8f0lk
10.26434/chemrxiv-2023-8f0lk · External reference
Chitosan functionalized Mn3O4 nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox state
10.1038/s42003-023-05023-6 · 2023 · External reference
Novel lipid-polymer hybrid nanoparticles for siRNA delivery and IGF-1R gene silencing in breast cancer cells
10.1016/j.jddst.2018.08.025 · 2018 · External reference
Multi-scale and multi-physics models of the transport of therapeutic/diagnostic cancer agents
2023 · External reference
Challenges and opportunities for the next generation of computational tumor models
10.1371/journal.pbio.3003269 · 2025 · External reference
AI drives optimization of delivery systems engineered for precise and effective immune-based Solutions
2026 · External reference
Feeding next‐generation nanomedicines to Europe: regulatory and quality challenges
10.1002/adhm.202301956 · 2023 · External reference
Challenges posed by the scale-up of nanomedicines
2012 · External reference
Artificial intelligence/machine learning and mechanistic modeling approaches as translational tools to advance personalized medicine decisions
10.1016/j.yamp.2022.06.003 · 2022 · External reference
Biophysical translational paradigm of polymeric nanoparticle: embarked advancement to brain tumor therapy
10.1016/j.biopha.2024.117372 · 2024 · External reference
Harnessing the power of D‐alpha‐tocopheryl polyethylene glycol succinate‐based nanoparticles for targeted breast cancer therapy
10.1002/wnan.70040 · 2025 · External reference
Green synthesis and characterization of gold-based anisotropic nanostructures using bimetallic nanoparticles as seeds
10.1039/d1dt02804a · 2021 · External reference
Hyaluronic acid-coated cubosomal in situ gel for Brimonidine Tartrate: a sustained delivery system with enhanced ocular bioavailability and intraocular pressure reduction
2025 · External reference
Comprehensive comparison of theranostic nanoparticles in breast cancer
2022 · External reference
Artificial intelligence in drug formulation and development: applications and future prospects
10.2174/0113892002265786230921062205 · 2023 · External reference
Hypoxia-inducible factors in breast cancer: prognostic indicators and emerging biomarkers: narrative review
10.1097/ms9.0000000000003500 · 2025 · External reference
Subtypes of breast cancer
2022 · External reference
Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs
2025 · External reference
Stimuli-responsive polymersomes for cancer therapy
10.1007/978-981-95-2744-1_4 · 2026 · External reference
Nanoinformatics: emerging databases and available tools
10.3390/ijms15057158 · 2014 · External reference
Implementing QbD for nano-pharmaceuticals and complex formulations to achieve predictable and high-quality outcomes
10.1208/s12249-025-03308-z · 2026 · External reference
Precision medicine in breast cancer
10.3892/mco.2024.2776 · 2024 · External reference
Brain‐Penetrating and disease site‐targeting manganese dioxide‐polymer‐lipid hybrid nanoparticles remodel microenvironment of Alzheimer's disease by regulating multiple pathological pathways
10.1002/advs.202207238 · 2023 · External reference
Adjuvant capecitabine in triple-negative breast cancer: new strategies for tailoring treatment recommendations
10.1001/jama.2020.23371 · 2021 · External reference
Nanoparticle-hydrogel composites for precision medicine
10.1016/j.celbio.2026.100372 · 2026 · External reference
A comprehensive analysis of natural bioactive molecules for the treatment and control of glioblastoma multiforme (GBM) targeting underlying molecular mechanism
10.1002/cbdv.202501413 · 2026 · External reference
Multimodal AI in biomedicine: pioneering the future of biomaterials, diagnostics, and personalized healthcare
10.3390/nano15120895 · 2025 · External reference
The changing paradigm for the treatment of HER2-positive breast cancer
10.3390/cancers12082081 · 2020 · External reference
A review: surface engineering of lipid‐based drug delivery systems
10.1002/smll.202401990 · 2024 · External reference
Nanoparticles in combating cancer: opportunities and limitations: a brief review
10.2174/0929867327666200130101605 · 2021 · External reference
Understanding, recognizing, and managing cancer-related fatigue associated with breast cancer
10.1007/s11864-026-01381-5 · 2026 · External reference
Lipid-polymer hybrid nanoparticles in cancer therapy: current overview and future directions
10.1088/2632-959x/abeb4b · 2021 · External reference
Building a hand-curated ceRNET for endometrial cancer, striving for clinical as well as medicolegal soundness: a systematic review
10.3390/ncrna11030034 · 2025 · External reference
Integrating artificial intelligence and quantum computing: A systematic literature review of features and applications
2026 · External reference
Integrating AI, Multi-omics, and nanomedicine in cancer therapy: a 5-year update across major solid tumors
2025 · External reference
Recent advances in targeted nanocarriers for the management of triple negative breast cancer
10.3390/pharmaceutics15010246 · 2023 · External reference
Surface-functionalised polymeric nanoparticles for breast cancer treatment: processes and advances
10.1080/1061186x.2024.2353359 · 2024 · External reference
Machine learning-based models to predict aquatic ecological risk for engineered nanoparticles: using hazard concentration for 5% of species as an endpoint
10.1007/s11356-024-32723-1 · 2024 · External reference
Combination therapy of metastatic castration-recurrent prostate cancer: hyaluronic acid decorated, cabazitaxel-prodrug and orlistat co-loaded nano-system
10.2147/dddt.s306684 · 2021 · External reference
In vivo MRI of breast cancer using carbonic anhydrase IX proteoglycan-like domain -targeting liposomes
10.1016/j.jconrel.2025.02.032 · 2025 · External reference
Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects
10.3762/bjnano.15.118 · 2024 · External reference
Physics informed machine learning for predictive toxicology and optimization of curcumin nanocarriers
2026 · External reference
Advances in nanoparticles-based approaches in cancer theranostics
10.1016/j.onano.2023.100152 · 2023 · External reference
Cell-based therapies and drug delivery: advancements and challenges
2025 · External reference
Decoration of Fe3O4-vitamin C nanoparticles on alginate-chitosan nanocomplex: characterization, safety, bioacessibility boost and Iron nanofortification in A2 goat milk gels
10.1016/j.foodchem.2024.142711 · 2025 · External reference
Exploring the potentials of hyaluronic acid-coated polymeric nanoparticles in enhanced cancer treatment by precision drug delivery, tackling drug resistance, and reshaping the tumour micro environment
10.2174/0109298673302510240328050115 · 2025 · External reference
Machine learning assisted exploration of the influential parameters on the PLGA nanoparticles
10.1038/s41598-023-50876-w · 2024 · External reference
Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies
10.1088/1361-6528/ac1098 · 2021 · External reference
Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks
2025 · External reference
Automated optimisation of solubility and conformational stability of antibodies and proteins
10.1038/s41467-023-37668-6 · 2023 · External reference
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening”(MyPeBS) randomised clinical trial
10.1186/s12885-022-09484-6 · 2022 · External reference
Machine learning applications in the mechanical analysis of nanomaterials and nanostructures
10.3390/app16020918 · 2026 · External reference
How nanoinformatics could pave the way to safer design of engineered nanomaterials?
10.3389/fnano.2025.1559053 · 2025 · External reference
Future perspectives-personalized nanomedicine and next-generation clinical trials in breast cancer
2025 · External reference
Lipid–polymer hybrid nanoparticles (LPHNPs) for RNA delivery
2026 · External reference
Simulation-based approaches for drug delivery systems: navigating advancements, opportunities, and challenges
10.1016/j.molliq.2023.123888 · 2024 · External reference
Artificial intelligence and personalized medication using nanodots
2026 · External reference
Scale-up and quality control challenges in the industrial manufacturing of nanoformulations: current trends and future perspectives. IJSAT-International Journal on
2025 · External reference
PEGylated drug delivery systems in the pharmaceutical field: past, present and future perspective
10.1080/03639045.2022.2101062 · 2022 · External reference
Lipid-polymer hybrid nanoparticles as a targeted drug delivery system for melanoma treatment
10.1080/00914037.2020.1809406 · 2022 · External reference
Real-world use and survival outcomes of sacituzumab govitecan in metastatic triple-negative breast cancer and hormone receptor-positive/HER2-negative metastatic breast cancer: epidemiology
2026 · External reference
An insight into aptamer engineered dendrimer for cancer therapy
10.1016/j.eurpolymj.2021.110746 · 2021 · External reference
Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics
10.1016/j.ijpharm.2022.121751 · 2022 · External reference
Accelerating materials discovery for polymer solar cells: Data-driven insights enabled by natural language processing
2024 · External reference
A drug-specific nanocarrier design for efficient anticancer therapy
10.1038/ncomms8449 · 2015 · External reference
Nano-formulations in disease therapy: designs, advances, challenges, and future directions
10.1186/s12951-025-03442-7 · 2025 · External reference
Artificial intelligence-assisted design of nanomedicines for breast cancer diagnosis and therapy: advances, challenges, and future directions
10.1007/s12668-025-01980-w · 2025 · External reference
Overcoming hurdles in nanoparticle clinical translation: the influence of experimental design and surface modification
10.3390/ijms20236056 · 2019 · External reference
Integrating multi-omics data: methods and applications in human complex diseases
2025 · External reference
10.3322/caac.20138
10.3322/caac.20138 · External reference
Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer
2026 · External reference
Artificial intelligence and machine learning in computational nanotoxicology: unlocking and empowering nanomedicine
10.1002/adhm.201901862 · 2020 · External reference
Artificial intelligence and machine learning empower advanced biomedical material design to toxicity prediction
10.1002/aisy.202070125 · 2020 · External reference
From bench to bedside: role of digital twins in nanocarrier pharmacokinetics and biodistribution
2025 · External reference
Artificial neural networks and neuro-fuzzy models: applications in pharmaceutical product development
10.1590/1678-4324-2023210769 · 2023 · External reference
Mutational landscape of cancer-driver genes across human cancers
10.1038/s41598-023-39608-2 · 2023 · External reference
Polymeric lipid hybrid nanoparticles (plns) as emerging drug delivery platform—a comprehensive review of their properties, preparation methods, and therapeutic applications
10.3390/pharmaceutics13081291 · 2021 · External reference
Translational paradigm of advanced nanoscale strategies for triple negative breast cancer (TNBC): mechanistic insights, metastatic pathways, and emerging theragnosis
10.1039/d5ma00866b · 2026 · External reference
Smart magnetic drug delivery systems for the treatment of cancer
10.3390/nano13050876 · 2023 · External reference
Encoding the space of protein-protein binding interfaces by artificial intelligence
10.1016/j.compbiolchem.2024.108080 · 2024 · External reference
Unresolved reference
External reference
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs
10.1016/j.dmpk.2021.100424 · 2021 · External reference
Nanoparticle-Mediated ferroptosis for cancer therapy: mechanisms and therapeutic strategies
10.2147/nsa.s550828 · 2025 · External reference
10.5772/intechopen.88269
10.5772/intechopen.88269 · External reference
Artificial intelligence aids in development of nanomedicines for cancer management
2023 · External reference
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study
10.1136/bmj-2022-074684 · 2023 · External reference
Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery
10.1021/acsnano.4c09566 · 2025 · External reference
Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapy
10.1016/j.nano.2021.102368 · 2021 · External reference
Multi-omics integration—a comparison of unsupervised clustering methodologies
10.1093/bib/bbx167 · 2019 · External reference
Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment
10.1007/s40005-019-00459-7 · 2020 · External reference
Nanofluidic detection platform for simultaneous light absorption and scattering measurement of individual nanoparticles in flow
10.1021/acs.analchem.4c01671 · 2024 · External reference
The breast cancer risk assessment pathway in England: a systems analysis of current challenges and ways to improve: epidemiology
2026 · External reference
Role of artificial intelligence and machine learning in advancing nanomedicine for breast cancer
2025 · External reference
Targeted delivery methods for anticancer drugs
10.3390/cancers14030622 · 2022 · External reference
Artificial intelligence in pharmaceutical technology and drug delivery design
10.3390/pharmaceutics15071916 · 2023 · External reference
From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling
10.1038/s41746-024-01188-4 · 2024 · External reference
Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor—Afatinib: in vitro and in vivo evaluation
10.1016/j.biopha.2019.109493 · 2019 · External reference
Enhanced gut-to-liver oral drug delivery via ligand-modified nanoparticles by attenuating protein corona adsorption
10.1021/acsnano.4c11453 · 2024 · External reference
Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy
2025 · External reference
Precision nanomedicine for cancer: innovations, strategies, and translational challenges
10.2147/ott.s550104 · 2025 · External reference
A call for an industry-led initiative to critically assess machine learning for real-world drug discovery
10.1038/s42256-024-00911-w · 2024 · External reference
Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing
10.1136/jitc-2020-002258 · 2021 · External reference
Breast cancer: pathogenesis and treatments
10.1038/s41392-024-02108-4 · 2025 · External reference
Efficient nose-to-brain delivery of chitosan-coated resveratrol nanoemulsion in rats: formulation optimized using D-optimal mixture design
10.1080/01932691.2025.2496390 · 2025 · External reference
Bridging the bioavailability barriers of apigenin via modern engineering strategies: a comprehensive and critical review
2026 · External reference
A nature‐inspired framework for dimensionality reduction and cancer diagnosis from gene expression profiles
10.1002/cpe.70562 · 2026 · External reference
Toward the scalable, rapid, reproducible, and cost-effective synthesis of personalized nanomedicines at the point of care
10.1021/acs.nanolett.3c04171 · 2024 · External reference
Unresolved reference
External reference
Pharmacokinetics and tumor delivery of nanoparticles
10.1016/j.jddst.2023.104404 · 2023 · External reference
Relationship between menopausal hormone therapy and breast cancer: a nationwide population‐based cohort study
10.1002/ijgo.15461 · 2024 · External reference
Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy
10.1007/s12672-025-02198-8 · 2025 · External reference
Stimulus switches for spatial-temporal precision in therapeutic delivery systems
2025 · External reference
pH-responsive lipid polymer hybrid nanoparticles (LPHNs) based on poly (β-amino ester) as a promising candidate to resist breast cancers
10.1016/j.jddst.2020.102102 · 2021 · External reference
Nanocarrier strategies for deep tumour penetration
10.1039/d5lp00154d · 2025 · External reference
A comprehensive review of explainable artificial intelligence in healthcare methods, evaluation, and clinical integration
2026 · External reference
DHAV-1 3C protein promotes viral proliferation by antagonizing type I interferon via upregulating the ANXA2 protein
10.1016/j.ijbiomac.2024.139040 · 2025 · External reference
Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor
10.1016/j.nano.2015.12.383 · 2016 · External reference
Navigating translational research in nanomedicine: A strategic guide to formulation and manufacturing
10.1016/j.ijpharm.2025.125202 · 2025 · External reference
Pharmacokinetics of Patisiran, the first approved RNA interference therapy in patients with hereditary transthyretin‐mediated amyloidosis
10.1002/jcph.1553 · 2020 · External reference
Wearable and implantable biosensors: mechanisms and applications in closed-loop therapeutic systems
10.1039/d4tb00782d · 2024 · External reference
OmicsNet 2.0: a web-based platform for multi-omics integration and network visual analytics
10.1093/nar/gkac376 · 2022 · External reference
Polymeric nanoparticles integrated from discrete organoplatinum (II) metallacycle by stepwise post-assembly polymerization for synergistic cancer therapy
10.1021/acs.chemmater.0c00615 · 2020 · External reference
Multi-step screening of DNA/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression
10.1038/s41467-022-31993-y · 2022 · External reference
Multifunctional nanocarrier drug delivery systems: from diverse design to precise biomedical applications
10.1002/adhm.202502178 · 2026 · External reference
Enhancing drug solubility, bioavailability, and targeted therapeutic applications through magnetic nanoparticles
10.3390/molecules29204854 · 2024 · External reference
Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN)
10.1080/10837450.2020.1744008 · 2020 · External reference
